RPID Rapid Micro Biosystems, Inc.: Multiplikator Forward P/S

Logo grafis Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems (RPID) pricing power is based on the sale of systems that require the mandatory use of proprietary consumables. The company's expected P/S confirms this cash dynamic, while 0.90 reflects the latest level of the metric. Growth prospects are linked to the automation of drug sterility via Growth Direct, and a moderate dependence on external electronics and logistics suppliers ensures production stability.

Rapid Micro Biosystems, Inc. - Rasio kapitalisasi marang dodolan sing dikarepake RPID (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan rapidmicrobio.com (RPID)

- rega saiki lan proyeksi nilai saham:
Rega saham Rapid Micro Biosystems, Inc.|RPID - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar Rapid Micro Biosystems, Inc.|RPID - Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham Rapid Micro Biosystems|RPID - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku rapidmicrobio.com|RPID - Gunggung Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Rapid Micro Biosystems|RPID - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Rapid Micro Biosystems, Inc.|RPID - Utang perusahaan|Utang marang nilai buku Rapid Micro Biosystems, Inc.|RPID - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rapid Micro Biosystems|Likuiditas cepet rapidmicrobio.com
- rincian asil keuangan lan kelipatan valuasi:
RPID - Bathi resik taunan|Bathi mangsa ngarep Rapid Micro Biosystems|RPID - Pangali P/E|Pangali Forward P/E Rapid Micro Biosystems, Inc.|RPID - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Rapid Micro Biosystems, Inc.|RPID - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Rapid Micro Biosystems|RPID - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan rapidmicrobio.com|RPID - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rapid Micro Biosystems
- indikator volume dodolan lan pendapatan:
RPID - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Rapid Micro Biosystems, Inc.|RPID - Kapitalisasi marang volume dodolan|Rasio rega marang prakiraan pendapatan Rapid Micro Biosystems, Inc.
Ringkesan analitik perusahaan:Rapid Micro (RPID)
Sampel barang Rapid Micro Biosystems, Inc.

To minimize fundamental risks, investors should select assets with a moderate discount that reflects the ratio of Rapid Micro Biosystems (RPID) market value to projected annual revenue. By analyzing the forward P/S ratio, an investor assesses the balance between market expectations and actual sales of automated control systems, where the stability of subscription revenues from biotech laboratories determines valuation resilience and protects capital from overpayment.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Semler (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network, Inc. BFLY|mesalabs.com - Rasio rega marang prakiraan pendapatan|QSI: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NNOX (Nano-X Imaging)|QTRX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep 908 Devices Corporation (MASS)|Rasio rega marang prakiraan pendapatan CapsoVision, Inc.|MXCT - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)